SHC - Lifshitz Law PLLC Announces Investigations of Sotera Health Co. (NASDAQ: SHC) Fate Therapeutics Inc. (NASDAQ: FATE) National Vision Holdings Inc. (NASDAQ: EYE) | Benzinga

NEW YORK, Sept. 09, 2023 (GLOBE NEWSWIRE) --

Sotera Health Co. (NASDAQ:SHC)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company's made false and misleading representations concerning its emissions control systems and exposure to liability from lawsuits for the Company's failure to limit harmful EtO emissions.

If you are a SHC investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

Fate Therapeutics, Inc. (NASDAQ:FATE)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) the Janssen Collaboration Agreement was less sustainable than Fate had represented to investors; (ii) accordingly, certain of the clinical programs, milestone payments, and royalty payments associated with the Janssen Collaboration Agreement could ...

SHC), Fate Therapeutics, Inc. (NASDAQ: FATE), National Vision Holdings, Inc. (NASDAQ: EYE)>Full story available on Benzinga.com